Ieq Capital LLC bought a new stake in shares of Concentrix Corporation (NASDAQ:CNXC - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 115,380 shares of the company's stock, valued at approximately $2,585,000. Ieq Capital LLC owned approximately 0.19% of Concentrix at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Larson Financial Group LLC increased its holdings in Concentrix by 224.9% in the 3rd quarter. Larson Financial Group LLC now owns 692 shares of the company's stock worth $32,000 after buying an additional 479 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock worth $34,000 after purchasing an additional 522 shares in the last quarter. Global Retirement Partners LLC increased its stake in Concentrix by 1,032.5% during the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company's stock worth $36,000 after buying an additional 795 shares in the last quarter. Webster Bank N. A. acquired a new stake in shares of Concentrix in the first quarter valued at about $41,000. Finally, Rothschild Investment LLC lifted its stake in Concentrix by 52.0% in the 4th quarter. Rothschild Investment LLC now owns 1,146 shares of the company's stock worth $48,000 after purchasing an additional 392 shares in the last quarter. Institutional investors and hedge funds own 90.34% of the company's stock.
Analyst Ratings Changes
Several research firms have commented on CNXC. Zacks Research downgraded shares of Concentrix from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 2nd. Bank of America cut their price objective on shares of Concentrix from $32.00 to $26.00 and set a "neutral" rating on the stock in a report on Tuesday, June 30th. Barrington Research reduced their target price on Concentrix from $38.00 to $30.00 and set an "outperform" rating for the company in a report on Tuesday, June 30th. Weiss Ratings reiterated a "sell (d)" rating on shares of Concentrix in a research note on Friday, July 24th. Finally, Robert W. Baird dropped their target price on Concentrix from $40.00 to $30.00 and set an "outperform" rating on the stock in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $32.75.
Read Our Latest Analysis on CNXC
Concentrix Stock Up 2.5%
CNXC stock opened at $26.03 on Tuesday. Concentrix Corporation has a 12 month low of $19.12 and a 12 month high of $57.88. The firm has a market capitalization of $1.59 billion, a PE ratio of -1.22, a P/E/G ratio of 0.47 and a beta of 0.45. The company's 50 day simple moving average is $24.42 and its 200-day simple moving average is $27.37. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18.
Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings data on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts' consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm's revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the business earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Equities analysts expect that Concentrix Corporation will post 9.67 earnings per share for the current fiscal year.
Concentrix Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th were paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 5.5%. The ex-dividend date of this dividend was Friday, July 24th. Concentrix's dividend payout ratio is currently -6.75%.
Concentrix Profile
(
Free Report)
Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Recommended Stories
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Concentrix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.
While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.